From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,593,128 shares, representing 2.11% for $0.89 million under the buyback announced on June 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 USD | -3.53% | -9.84% | -73.04% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TOI) TOI MANAGEMENT LLC Reports Q1 Revenue $94.7M, vs. Street Est of $95.2M | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-73.04% | 39.08M | |
+16.99% | 83.47B | |
-31.69% | 69.72B | |
-3.24% | 26.37B | |
+4.13% | 17.86B | |
-13.37% | 16.83B | |
+0.81% | 15.7B | |
+74.17% | 13.45B | |
+72.59% | 12.81B | |
-2.89% | 12.44B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on June 15, 2023.